Undiscovered Gems in India to Watch This September 2024
In This Article:
Over the past 7 days, the Indian market has risen 1.8%, and over the past 12 months, it is up an impressive 41%. In this thriving environment where earnings are expected to grow by 17% per annum over the next few years, identifying stocks with strong fundamentals and growth potential can be particularly rewarding.
Top 10 Undiscovered Gems With Strong Fundamentals In India
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Bharat Rasayan | 8.15% | 0.10% | -7.93% | ★★★★★★ |
| Le Travenues Technology | 10.32% | 26.39% | 67.32% | ★★★★★★ |
| TechNVision Ventures | 100.73% | 20.37% | 68.50% | ★★★★★★ |
| Indo Tech Transformers | 2.30% | 22.05% | 60.31% | ★★★★★☆ |
| BLS E-Services | 1.67% | 15.04% | 51.58% | ★★★★★☆ |
| JSW Holdings | NA | 21.35% | 22.41% | ★★★★★☆ |
| Kalyani Investment | NA | 20.74% | 6.35% | ★★★★★☆ |
| Sky Gold | 127.01% | 22.02% | 48.03% | ★★★★☆☆ |
| Innovana Thinklabs | 13.59% | 12.51% | 20.01% | ★★★★☆☆ |
| SG Mart | 16.77% | 98.09% | 96.54% | ★★★★☆☆ |
Let's dive into some prime choices out of from the screener.
LT Foods
Simply Wall St Value Rating: ★★★★★★
Overview: LT Foods Limited specializes in the milling, processing, and marketing of branded and non-branded basmati rice and rice food products in India, with a market cap of ?152.77 billion.
Operations: The primary revenue stream for LT Foods Limited is the manufacture and storage of rice, generating ?81.21 billion.
Earnings at LT Foods surged by 35.7% last year, outpacing the food industry’s 16.7% growth. The company’s price-to-earnings ratio stands at 25x, notably lower than the Indian market average of 34.6x, indicating good value relative to peers. Debt to equity has significantly improved from 116.4% to 26.8% over five years, with interest payments well covered by EBIT (10.8x). Additionally, LT Foods remains profitable and free cash flow positive despite recent regulatory challenges and legal notices impacting operations minimally with fines up to INR100K (~US$1K).
-
Click to explore a detailed breakdown of our findings in LT Foods' health report.
-
Examine LT Foods' past performance report to understand how it has performed in the past.
Marksans Pharma
Simply Wall St Value Rating: ★★★★★★
Overview: Marksans Pharma Limited, along with its subsidiaries, focuses on the research, manufacturing, marketing, and sale of pharmaceutical formulations across various international markets including the United States, North America, Europe, the United Kingdom, Australia, and New Zealand; it has a market cap of ?134.31 billion.
Operations: Marksans Pharma generates its revenue primarily from the sale of pharmaceutical formulations, amounting to ?22.68 billion. The company operates across various international markets including the United States, North America, Europe, the United Kingdom, Australia, and New Zealand.